Literature DB >> 6776012

Mucosal damage mediated by clostridial toxin in experimental clindamycin-associated colitis.

G D Abrams, M Allo, G D Rifkin, R Fekety, J Silva.   

Abstract

A toxin produced by Clostridium difficile has been implicated in the pathogenesis of antibiotic-associated colitis in humans and experimental animals. This study was undertaken in order to define the sequential evolution of caecal mucosal lesions in the hamster and to relate those lesions directly to the clostridial toxin. Sterile filtrates from a culture of C. difficile and from caecal contents of clindamycin-treated hamsters were studied with respect to their effects on the caecal mucosa and on cultured cell monolayers. The toxic filtrates both produced cellular swelling in vitro, and appeared to have a similar cytotoxic effect on caecal epithelial cells in vivo. Cellular damage was followed by extensive epithelial desquamation and the evolution of an acute pseudomembranous typhlitis. The pathogenetic sequence produced by the filtrates was identical with that previously described after direct clindamycin treatment. These findings demonstrate that intraluminal clostridial toxin can mediate development of the characteristic antibiotic-associated mucosal lesions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776012      PMCID: PMC1419662          DOI: 10.1136/gut.21.6.493

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  The protective effect of vancomycin on clindamycin-induced colitis in hamsters.

Authors:  R A Browne; R Fekety; J Silva; D I Boyd; C O Work; G D Abrams
Journal:  Johns Hopkins Med J       Date:  1977-10

Review 2.  Pseudomembranous enterocolitis (antibiotic-related colitis).

Authors:  J G Bartlett; S L Gorbach
Journal:  Adv Intern Med       Date:  1977

3.  Pseudomembranous colitis.

Authors:  A B Price; D R Davies
Journal:  J Clin Pathol       Date:  1977-01       Impact factor: 3.411

4.  Identification of Clostridium difficile as a cause of pseudomembranous colitis.

Authors:  R H George; J M Symonds; F Dimock; J D Brown; Y Arabi; N Shinagawa; M R Keighley; J Alexander-Williams; D W Burdon
Journal:  Br Med J       Date:  1978-03-18

5.  Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters.

Authors:  J G Bartlett; A B Onderdonk; R L Cisneros; D L Kasper
Journal:  J Infect Dis       Date:  1977-11       Impact factor: 5.226

6.  Undescribed toxin in pseudomembranous colitis.

Authors:  H E Larson; J V Parry; A B Price; D R Davies; J Dolby; D A Tyrrell
Journal:  Br Med J       Date:  1977-05-14

7.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

8.  Clindamycin-induced enterocolitis in hamsters.

Authors:  R H Lusk; R Fekety; J Silva; R A Browne; D H Ringler; G D Abrams
Journal:  J Infect Dis       Date:  1978-04       Impact factor: 5.226

9.  Pseudomembranous colitis: Presence of clostridial toxin.

Authors:  H E Larson; A B Price
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

10.  Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin.

Authors:  G D Rifkin; F R Fekety; J Silva
Journal:  Lancet       Date:  1977-11-26       Impact factor: 79.321

View more
  13 in total

1.  TcdB from hypervirulent Clostridium difficile exhibits increased efficiency of autoprocessing.

Authors:  Jordi M Lanis; Logan D Hightower; Aimee Shen; Jimmy D Ballard
Journal:  Mol Microbiol       Date:  2012-02-28       Impact factor: 3.501

2.  Mouse relapse model of Clostridium difficile infection.

Authors:  Xingmin Sun; Haiying Wang; Yongrong Zhang; Kevin Chen; Barbara Davis; Hanping Feng
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

3.  Enterotoxins from Clostridium difficile; diarrhoeogenic potency and morphological effects in the rat intestine.

Authors:  J Torres; E Jennische; S Lange; I Lönnroth
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

Review 4.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

5.  Production of antitoxins to two toxins of Clostridium difficile and immunological comparison of the toxins by cross-neutralization studies.

Authors:  J M Libby; T D Wilkins
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

6.  Differential effects of Clostridium difficile toxins on tissue-cultured cells.

Authors:  S T Donta; N Sullivan; T D Wilkins
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

7.  Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.

Authors:  Simon A Hirota; Vadim Iablokov; Sarah E Tulk; L Patrick Schenck; Helen Becker; Jimmie Nguyen; Samir Al Bashir; Tanis C Dingle; Austin Laing; Jianrui Liu; Yan Li; Jeff Bolstad; George L Mulvey; Glen D Armstrong; Wallace K MacNaughton; Daniel A Muruve; Justin A MacDonald; Paul L Beck
Journal:  Infect Immun       Date:  2012-10-08       Impact factor: 3.441

Review 8.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

9.  Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor.

Authors:  R Eglow; C Pothoulakis; S Itzkowitz; E J Israel; C J O'Keane; D Gong; N Gao; Y L Xu; W A Walker; J T LaMont
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

10.  Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G protein.

Authors:  C Pothoulakis; J T LaMont; R Eglow; N Gao; J B Rubins; T C Theoharides; B F Dickey
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.